ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2025; 15(7): 2938-2947


Sedative Effects of the Combination of Detomidine and Midazolam In Horses

Erika ribeiro gomes, larissa alexsandra felix, lucas wamser fonseca gonzaga, naira fernanda dias da silva, bruna christina fernandes soares soares, joão vitor fernandes cotrim fernandes cotrim de almeida, gabriela pereira souza, rodrigo norberto pereira, marilda onghero taffarel, marcos ferrante.



Abstract
Download PDF Cited by 0 ArticlesPost

Background: The combination of detomidine and midazolam may provide safer sedation with muscle-relaxant effects, which is particularly necessary during standing procedures.
Aim: Thus, the objective of this study was to evaluate the sedative and muscle-relaxant effects of the detomidine-midazolam combination in horses through a pharmacodynamic study.
Methods: Five horses were used and subjected to four experimental protocols: 15 µg/kg of detomidine (D15); a combination of detomidine (15 µg/kg) with 25 µg/kg (DM25), 50 µg/kg (DM50), or 75 µg/kg (DM75) of midazolam, administered intravenously. Sedative and muscle-relaxant effects, as well as physiological parameters, were evaluated and statistically analyzed.
Results: All protocols resulted in a decrease in head height, although no significant difference was observed among them. Acoustic stimulus response and tongue tone relaxation showed significant effects in the global analysis.
Conclusion: This study contributes to the understanding and application of this combination in equine sedation protocols.

Key words: sedation, α-2 agonists, benzodiazepines, chemical restraint







Bibliomed Article Statistics

26
17
14
18
4
R
E
A
D
S

37

11

13

12

2
D
O
W
N
L
O
A
D
S
0809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.